nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Vincristine—muscle cancer	0.179	0.202	CbGbCtD
Tenofovir—ABCC10—Etoposide—muscle cancer	0.164	0.185	CbGbCtD
Tenofovir—ABCC10—Doxorubicin—muscle cancer	0.112	0.126	CbGbCtD
Tenofovir—ABCC10—Methotrexate—muscle cancer	0.108	0.123	CbGbCtD
Tenofovir—ABCC4—Methotrexate—muscle cancer	0.0521	0.0589	CbGbCtD
Tenofovir—ABCC2—Vincristine—muscle cancer	0.0511	0.0578	CbGbCtD
Tenofovir—ABCC2—Etoposide—muscle cancer	0.0469	0.053	CbGbCtD
Tenofovir—CYP1A2—Dacarbazine—muscle cancer	0.0357	0.0404	CbGbCtD
Tenofovir—SLC22A8—Methotrexate—muscle cancer	0.0325	0.0368	CbGbCtD
Tenofovir—ABCC2—Doxorubicin—muscle cancer	0.032	0.0362	CbGbCtD
Tenofovir—ABCC2—Methotrexate—muscle cancer	0.031	0.035	CbGbCtD
Tenofovir—SLC22A6—Methotrexate—muscle cancer	0.0227	0.0256	CbGbCtD
Tenofovir—CYP1A2—Etoposide—muscle cancer	0.0175	0.0198	CbGbCtD
Tenofovir—NME2—embryo—muscle cancer	0.00337	0.0581	CbGeAlD
Tenofovir—NME1-NME2—head—muscle cancer	0.00312	0.0537	CbGeAlD
Tenofovir—AK2—tendon—muscle cancer	0.00276	0.0475	CbGeAlD
Tenofovir—NME1—renal system—muscle cancer	0.00271	0.0467	CbGeAlD
Tenofovir—AK2—bone marrow—muscle cancer	0.00267	0.046	CbGeAlD
Tenofovir—AK4—renal system—muscle cancer	0.00261	0.045	CbGeAlD
Tenofovir—AK2—vagina—muscle cancer	0.00256	0.0441	CbGeAlD
Tenofovir—NME2—renal system—muscle cancer	0.00255	0.044	CbGeAlD
Tenofovir—AK4—cardiac atrium—muscle cancer	0.00234	0.0403	CbGeAlD
Tenofovir—AK2—testis—muscle cancer	0.00228	0.0393	CbGeAlD
Tenofovir—NME1—bone marrow—muscle cancer	0.00205	0.0353	CbGeAlD
Tenofovir—AK4—tendon—muscle cancer	0.00204	0.0351	CbGeAlD
Tenofovir—AK4—vagina—muscle cancer	0.00189	0.0326	CbGeAlD
Tenofovir—NME1—head—muscle cancer	0.00181	0.0312	CbGeAlD
Tenofovir—NME1—testis—muscle cancer	0.00175	0.0302	CbGeAlD
Tenofovir—AK4—head—muscle cancer	0.00175	0.0301	CbGeAlD
Tenofovir—NME2—head—muscle cancer	0.00171	0.0294	CbGeAlD
Tenofovir—AK4—testis—muscle cancer	0.00169	0.0291	CbGeAlD
Tenofovir—NME2—testis—muscle cancer	0.00165	0.0284	CbGeAlD
Tenofovir—Lactic acidosis—Doxorubicin—muscle cancer	0.00153	0.0283	CcSEcCtD
Tenofovir—Hepatomegaly—Dactinomycin—muscle cancer	0.00141	0.026	CcSEcCtD
Tenofovir—ABCC10—renal system—muscle cancer	0.00124	0.0214	CbGeAlD
Tenofovir—ABCC10—cardiac atrium—muscle cancer	0.00111	0.0191	CbGeAlD
Tenofovir—ABCC4—renal system—muscle cancer	0.00103	0.0177	CbGeAlD
Tenofovir—SLC22A8—renal system—muscle cancer	0.00102	0.0176	CbGeAlD
Tenofovir—ABCC2—renal system—muscle cancer	0.000995	0.0171	CbGeAlD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—PTMA—muscle cancer	0.000978	0.277	CbGpPWpGaD
Tenofovir—ABCC10—tendon—muscle cancer	0.000967	0.0167	CbGeAlD
Tenofovir—ABCC10—bone marrow—muscle cancer	0.000937	0.0161	CbGeAlD
Tenofovir—Bone pain—Vincristine—muscle cancer	0.00093	0.0171	CcSEcCtD
Tenofovir—ABCC10—vagina—muscle cancer	0.000897	0.0155	CbGeAlD
Tenofovir—Urine output increased—Vincristine—muscle cancer	0.000805	0.0148	CcSEcCtD
Tenofovir—ABCC4—tendon—muscle cancer	0.000802	0.0138	CbGeAlD
Tenofovir—ABCC10—testis—muscle cancer	0.000801	0.0138	CbGeAlD
Tenofovir—ABCC4—bone marrow—muscle cancer	0.000777	0.0134	CbGeAlD
Tenofovir—ABCC2—tendon—muscle cancer	0.000776	0.0134	CbGeAlD
Tenofovir—Multiple fractures—Methotrexate—muscle cancer	0.000744	0.0137	CcSEcCtD
Tenofovir—Fracture—Methotrexate—muscle cancer	0.000744	0.0137	CcSEcCtD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—PTMA—muscle cancer	0.000741	0.21	CbGpPWpGaD
Tenofovir—Polyuria—Vincristine—muscle cancer	0.000736	0.0136	CcSEcCtD
Tenofovir—CYP1A2—renal system—muscle cancer	0.000698	0.012	CbGeAlD
Tenofovir—ABCC4—head—muscle cancer	0.000688	0.0118	CbGeAlD
Tenofovir—SLC22A8—head—muscle cancer	0.000682	0.0118	CbGeAlD
Tenofovir—ABCC4—testis—muscle cancer	0.000664	0.0114	CbGeAlD
Tenofovir—Hypophosphataemia—Doxorubicin—muscle cancer	0.000644	0.0119	CcSEcCtD
Tenofovir—ABCC2—testis—muscle cancer	0.000643	0.0111	CbGeAlD
Tenofovir—Serum creatinine increased—Doxorubicin—muscle cancer	0.000608	0.0112	CcSEcCtD
Tenofovir—Muscular weakness—Vincristine—muscle cancer	0.00057	0.0105	CcSEcCtD
Tenofovir—Pneumonia—Dactinomycin—muscle cancer	0.000561	0.0103	CcSEcCtD
Tenofovir—Hepatomegaly—Doxorubicin—muscle cancer	0.000529	0.00975	CcSEcCtD
Tenofovir—Weight decreased—Vincristine—muscle cancer	0.000505	0.00932	CcSEcCtD
Tenofovir—Pneumonia—Vincristine—muscle cancer	0.000501	0.00924	CcSEcCtD
Tenofovir—Hepatitis—Dactinomycin—muscle cancer	0.000501	0.00923	CcSEcCtD
Tenofovir—Depression—Vincristine—muscle cancer	0.000497	0.00916	CcSEcCtD
Tenofovir—Proteinuria—Methotrexate—muscle cancer	0.000492	0.00907	CcSEcCtD
Tenofovir—Neuropathy peripheral—Vincristine—muscle cancer	0.000488	0.009	CcSEcCtD
Tenofovir—Protein urine present—Methotrexate—muscle cancer	0.000485	0.00894	CcSEcCtD
Tenofovir—Sweating—Vincristine—muscle cancer	0.000478	0.00881	CcSEcCtD
Tenofovir—Glycosuria—Doxorubicin—muscle cancer	0.000462	0.00852	CcSEcCtD
Tenofovir—Urinary tract disorder—Vincristine—muscle cancer	0.000442	0.00814	CcSEcCtD
Tenofovir—Connective tissue disorder—Vincristine—muscle cancer	0.000439	0.0081	CcSEcCtD
Tenofovir—Urethral disorder—Vincristine—muscle cancer	0.000438	0.00808	CcSEcCtD
Tenofovir—Pneumonia—Etoposide—muscle cancer	0.000406	0.00748	CcSEcCtD
Tenofovir—Infestation NOS—Etoposide—muscle cancer	0.000404	0.00744	CcSEcCtD
Tenofovir—Infestation—Etoposide—muscle cancer	0.000404	0.00744	CcSEcCtD
Tenofovir—Mediastinal disorder—Vincristine—muscle cancer	0.000403	0.00743	CcSEcCtD
Tenofovir—Renal failure—Etoposide—muscle cancer	0.000397	0.00731	CcSEcCtD
Tenofovir—Neuropathy peripheral—Etoposide—muscle cancer	0.000396	0.00729	CcSEcCtD
Tenofovir—Creatinine increased—Doxorubicin—muscle cancer	0.000393	0.00725	CcSEcCtD
Tenofovir—Mental disorder—Vincristine—muscle cancer	0.000392	0.00722	CcSEcCtD
Tenofovir—Urine output increased—Methotrexate—muscle cancer	0.000391	0.0072	CcSEcCtD
Tenofovir—Bone pain—Doxorubicin—muscle cancer	0.000391	0.0072	CcSEcCtD
Tenofovir—Hepatobiliary disease—Etoposide—muscle cancer	0.000382	0.00704	CcSEcCtD
Tenofovir—Back pain—Vincristine—muscle cancer	0.000377	0.00694	CcSEcCtD
Tenofovir—Myalgia—Dactinomycin—muscle cancer	0.000371	0.00684	CcSEcCtD
Tenofovir—Urinary tract disorder—Etoposide—muscle cancer	0.000358	0.0066	CcSEcCtD
Tenofovir—Polyuria—Methotrexate—muscle cancer	0.000357	0.00659	CcSEcCtD
Tenofovir—Urethral disorder—Etoposide—muscle cancer	0.000355	0.00655	CcSEcCtD
Tenofovir—Renal failure acute—Methotrexate—muscle cancer	0.00034	0.00626	CcSEcCtD
Tenofovir—Anorexia—Dactinomycin—muscle cancer	0.000339	0.00625	CcSEcCtD
Tenofovir—Myalgia—Vincristine—muscle cancer	0.000331	0.00611	CcSEcCtD
Tenofovir—Immune system disorder—Etoposide—muscle cancer	0.000327	0.00603	CcSEcCtD
Tenofovir—Mediastinal disorder—Etoposide—muscle cancer	0.000326	0.00602	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000324	0.00597	CcSEcCtD
Tenofovir—Nervous system disorder—Vincristine—muscle cancer	0.000312	0.00575	CcSEcCtD
Tenofovir—Decreased appetite—Dactinomycin—muscle cancer	0.000309	0.0057	CcSEcCtD
Tenofovir—Hyperhidrosis—Vincristine—muscle cancer	0.000307	0.00566	CcSEcCtD
Tenofovir—Fatigue—Dactinomycin—muscle cancer	0.000307	0.00565	CcSEcCtD
Tenofovir—Back pain—Etoposide—muscle cancer	0.000305	0.00562	CcSEcCtD
Tenofovir—Pain—Dactinomycin—muscle cancer	0.000304	0.00561	CcSEcCtD
Tenofovir—Anorexia—Vincristine—muscle cancer	0.000303	0.00558	CcSEcCtD
Tenofovir—Renal failure acute—Doxorubicin—muscle cancer	0.000294	0.00542	CcSEcCtD
Tenofovir—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000291	0.00536	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000289	0.00534	CcSEcCtD
Tenofovir—Insomnia—Vincristine—muscle cancer	0.000287	0.0053	CcSEcCtD
Tenofovir—Renal impairment—Doxorubicin—muscle cancer	0.000285	0.00526	CcSEcCtD
Tenofovir—Body temperature increased—Dactinomycin—muscle cancer	0.000281	0.00518	CcSEcCtD
Tenofovir—Abdominal pain—Dactinomycin—muscle cancer	0.000281	0.00518	CcSEcCtD
Tenofovir—Decreased appetite—Vincristine—muscle cancer	0.000276	0.00509	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Vincristine—muscle cancer	0.000274	0.00506	CcSEcCtD
Tenofovir—Fatigue—Vincristine—muscle cancer	0.000274	0.00505	CcSEcCtD
Tenofovir—Pain—Vincristine—muscle cancer	0.000272	0.00501	CcSEcCtD
Tenofovir—Chest pain—Etoposide—muscle cancer	0.000268	0.00495	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000267	0.00492	CcSEcCtD
Tenofovir—Pancreatitis—Methotrexate—muscle cancer	0.000266	0.0049	CcSEcCtD
Tenofovir—Hypersensitivity—Dactinomycin—muscle cancer	0.000262	0.00483	CcSEcCtD
Tenofovir—Gastrointestinal pain—Vincristine—muscle cancer	0.00026	0.00479	CcSEcCtD
Tenofovir—Asthenia—Dactinomycin—muscle cancer	0.000255	0.0047	CcSEcCtD
Tenofovir—Blood creatinine increased—Doxorubicin—muscle cancer	0.000254	0.00469	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000252	0.00465	CcSEcCtD
Tenofovir—Abdominal pain—Vincristine—muscle cancer	0.000251	0.00463	CcSEcCtD
Tenofovir—Body temperature increased—Vincristine—muscle cancer	0.000251	0.00463	CcSEcCtD
Tenofovir—Skin disorder—Etoposide—muscle cancer	0.00025	0.00461	CcSEcCtD
Tenofovir—Hyperhidrosis—Etoposide—muscle cancer	0.000249	0.00459	CcSEcCtD
Tenofovir—Hypokalaemia—Doxorubicin—muscle cancer	0.000247	0.00456	CcSEcCtD
Tenofovir—Anorexia—Etoposide—muscle cancer	0.000245	0.00452	CcSEcCtD
Tenofovir—Diarrhoea—Dactinomycin—muscle cancer	0.000243	0.00449	CcSEcCtD
Tenofovir—Pneumonia—Methotrexate—muscle cancer	0.000243	0.00448	CcSEcCtD
Tenofovir—Nasopharyngitis—Doxorubicin—muscle cancer	0.000243	0.00448	CcSEcCtD
Tenofovir—Infestation—Methotrexate—muscle cancer	0.000242	0.00446	CcSEcCtD
Tenofovir—Infestation NOS—Methotrexate—muscle cancer	0.000242	0.00446	CcSEcCtD
Tenofovir—Depression—Methotrexate—muscle cancer	0.000241	0.00444	CcSEcCtD
Tenofovir—Muscular weakness—Doxorubicin—muscle cancer	0.00024	0.00442	CcSEcCtD
Tenofovir—Renal failure—Methotrexate—muscle cancer	0.000238	0.00438	CcSEcCtD
Tenofovir—Hypersensitivity—Vincristine—muscle cancer	0.000234	0.00432	CcSEcCtD
Tenofovir—Sweating—Methotrexate—muscle cancer	0.000232	0.00427	CcSEcCtD
Tenofovir—Haematuria—Methotrexate—muscle cancer	0.00023	0.00425	CcSEcCtD
Tenofovir—Pancreatitis—Doxorubicin—muscle cancer	0.00023	0.00424	CcSEcCtD
Tenofovir—Dyspnoea—Etoposide—muscle cancer	0.000229	0.00423	CcSEcCtD
Tenofovir—Hepatobiliary disease—Methotrexate—muscle cancer	0.000229	0.00422	CcSEcCtD
Tenofovir—Asthenia—Vincristine—muscle cancer	0.000228	0.0042	CcSEcCtD
Tenofovir—Vomiting—Dactinomycin—muscle cancer	0.000226	0.00417	CcSEcCtD
Tenofovir—Rash—Dactinomycin—muscle cancer	0.000224	0.00413	CcSEcCtD
Tenofovir—Decreased appetite—Etoposide—muscle cancer	0.000224	0.00413	CcSEcCtD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—HMGA1—muscle cancer	0.000224	0.0633	CbGpPWpGaD
Tenofovir—Gastrointestinal disorder—Etoposide—muscle cancer	0.000222	0.0041	CcSEcCtD
Tenofovir—Fatigue—Etoposide—muscle cancer	0.000222	0.00409	CcSEcCtD
Tenofovir—Pain—Etoposide—muscle cancer	0.00022	0.00406	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000218	0.00402	CcSEcCtD
Tenofovir—Diarrhoea—Vincristine—muscle cancer	0.000217	0.00401	CcSEcCtD
Tenofovir—Hepatitis—Methotrexate—muscle cancer	0.000217	0.004	CcSEcCtD
Tenofovir—Urinary tract disorder—Methotrexate—muscle cancer	0.000214	0.00395	CcSEcCtD
Tenofovir—Urethral disorder—Methotrexate—muscle cancer	0.000213	0.00392	CcSEcCtD
Tenofovir—Weight decreased—Doxorubicin—muscle cancer	0.000212	0.00392	CcSEcCtD
Tenofovir—Hyperglycaemia—Doxorubicin—muscle cancer	0.000212	0.0039	CcSEcCtD
Tenofovir—Nausea—Dactinomycin—muscle cancer	0.000211	0.00389	CcSEcCtD
Tenofovir—Pneumonia—Doxorubicin—muscle cancer	0.000211	0.00388	CcSEcCtD
Tenofovir—Gastrointestinal pain—Etoposide—muscle cancer	0.00021	0.00388	CcSEcCtD
Tenofovir—Dizziness—Vincristine—muscle cancer	0.00021	0.00387	CcSEcCtD
Tenofovir—Infestation NOS—Doxorubicin—muscle cancer	0.000209	0.00386	CcSEcCtD
Tenofovir—Infestation—Doxorubicin—muscle cancer	0.000209	0.00386	CcSEcCtD
Tenofovir—Renal failure—Doxorubicin—muscle cancer	0.000206	0.00379	CcSEcCtD
Tenofovir—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000205	0.00378	CcSEcCtD
Tenofovir—Abdominal pain—Etoposide—muscle cancer	0.000203	0.00375	CcSEcCtD
Tenofovir—Body temperature increased—Etoposide—muscle cancer	0.000203	0.00375	CcSEcCtD
Tenofovir—Vomiting—Vincristine—muscle cancer	0.000202	0.00372	CcSEcCtD
Tenofovir—Sweating—Doxorubicin—muscle cancer	0.000201	0.0037	CcSEcCtD
Tenofovir—Rash—Vincristine—muscle cancer	0.0002	0.00369	CcSEcCtD
Tenofovir—Dermatitis—Vincristine—muscle cancer	0.0002	0.00369	CcSEcCtD
Tenofovir—Haematuria—Doxorubicin—muscle cancer	0.0002	0.00368	CcSEcCtD
Tenofovir—Headache—Vincristine—muscle cancer	0.000199	0.00367	CcSEcCtD
Tenofovir—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000198	0.00365	CcSEcCtD
Tenofovir—Sinusitis—Doxorubicin—muscle cancer	0.000196	0.00362	CcSEcCtD
Tenofovir—Immune system disorder—Methotrexate—muscle cancer	0.000196	0.00361	CcSEcCtD
Tenofovir—Mediastinal disorder—Methotrexate—muscle cancer	0.000196	0.00361	CcSEcCtD
Tenofovir—Mental disorder—Methotrexate—muscle cancer	0.00019	0.00351	CcSEcCtD
Tenofovir—Hypersensitivity—Etoposide—muscle cancer	0.00019	0.0035	CcSEcCtD
Tenofovir—Malnutrition—Methotrexate—muscle cancer	0.000189	0.00348	CcSEcCtD
Tenofovir—Nausea—Vincristine—muscle cancer	0.000189	0.00348	CcSEcCtD
Tenofovir—Hepatitis—Doxorubicin—muscle cancer	0.000188	0.00346	CcSEcCtD
Tenofovir—Urinary tract disorder—Doxorubicin—muscle cancer	0.000186	0.00342	CcSEcCtD
Tenofovir—Asthenia—Etoposide—muscle cancer	0.000185	0.0034	CcSEcCtD
Tenofovir—Connective tissue disorder—Doxorubicin—muscle cancer	0.000185	0.0034	CcSEcCtD
Tenofovir—Urethral disorder—Doxorubicin—muscle cancer	0.000184	0.0034	CcSEcCtD
Tenofovir—Back pain—Methotrexate—muscle cancer	0.000183	0.00337	CcSEcCtD
Tenofovir—Pruritus—Etoposide—muscle cancer	0.000182	0.00336	CcSEcCtD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—IGF2—muscle cancer	0.000182	0.0514	CbGpPWpGaD
Tenofovir—Diarrhoea—Etoposide—muscle cancer	0.000176	0.00325	CcSEcCtD
Tenofovir—Dizziness—Etoposide—muscle cancer	0.00017	0.00314	CcSEcCtD
Tenofovir—Immune system disorder—Doxorubicin—muscle cancer	0.00017	0.00313	CcSEcCtD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—HMGA1—muscle cancer	0.000169	0.048	CbGpPWpGaD
Tenofovir—Mediastinal disorder—Doxorubicin—muscle cancer	0.000169	0.00312	CcSEcCtD
Tenofovir—Mental disorder—Doxorubicin—muscle cancer	0.000165	0.00304	CcSEcCtD
Tenofovir—Vomiting—Etoposide—muscle cancer	0.000164	0.00302	CcSEcCtD
Tenofovir—Malnutrition—Doxorubicin—muscle cancer	0.000164	0.00302	CcSEcCtD
Tenofovir—Rash—Etoposide—muscle cancer	0.000162	0.00299	CcSEcCtD
Tenofovir—Dermatitis—Etoposide—muscle cancer	0.000162	0.00299	CcSEcCtD
Tenofovir—Headache—Etoposide—muscle cancer	0.000161	0.00297	CcSEcCtD
Tenofovir—Flatulence—Doxorubicin—muscle cancer	0.000161	0.00297	CcSEcCtD
Tenofovir—Arthralgia—Methotrexate—muscle cancer	0.000161	0.00297	CcSEcCtD
Tenofovir—Chest pain—Methotrexate—muscle cancer	0.000161	0.00297	CcSEcCtD
Tenofovir—Myalgia—Methotrexate—muscle cancer	0.000161	0.00297	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00016	0.00294	CcSEcCtD
Tenofovir—Back pain—Doxorubicin—muscle cancer	0.000158	0.00292	CcSEcCtD
Tenofovir—Nausea—Etoposide—muscle cancer	0.000153	0.00282	CcSEcCtD
Tenofovir—Nervous system disorder—Methotrexate—muscle cancer	0.000151	0.00279	CcSEcCtD
Tenofovir—Skin disorder—Methotrexate—muscle cancer	0.00015	0.00276	CcSEcCtD
Tenofovir—Hyperhidrosis—Methotrexate—muscle cancer	0.000149	0.00275	CcSEcCtD
Tenofovir—Anorexia—Methotrexate—muscle cancer	0.000147	0.00271	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00014	0.00259	CcSEcCtD
Tenofovir—Insomnia—Methotrexate—muscle cancer	0.000139	0.00257	CcSEcCtD
Tenofovir—Myalgia—Doxorubicin—muscle cancer	0.000139	0.00257	CcSEcCtD
Tenofovir—Arthralgia—Doxorubicin—muscle cancer	0.000139	0.00257	CcSEcCtD
Tenofovir—Chest pain—Doxorubicin—muscle cancer	0.000139	0.00257	CcSEcCtD
Tenofovir—Anxiety—Doxorubicin—muscle cancer	0.000139	0.00256	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000138	0.00255	CcSEcCtD
Tenofovir—Dyspnoea—Methotrexate—muscle cancer	0.000137	0.00253	CcSEcCtD
Tenofovir—Dyspepsia—Methotrexate—muscle cancer	0.000136	0.0025	CcSEcCtD
Tenofovir—Decreased appetite—Methotrexate—muscle cancer	0.000134	0.00247	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000133	0.00245	CcSEcCtD
Tenofovir—Fatigue—Methotrexate—muscle cancer	0.000133	0.00245	CcSEcCtD
Tenofovir—Pain—Methotrexate—muscle cancer	0.000132	0.00243	CcSEcCtD
Tenofovir—Nervous system disorder—Doxorubicin—muscle cancer	0.000131	0.00241	CcSEcCtD
Tenofovir—Skin disorder—Doxorubicin—muscle cancer	0.00013	0.00239	CcSEcCtD
Tenofovir—Hyperhidrosis—Doxorubicin—muscle cancer	0.000129	0.00238	CcSEcCtD
Tenofovir—Anorexia—Doxorubicin—muscle cancer	0.000127	0.00235	CcSEcCtD
Tenofovir—Gastrointestinal pain—Methotrexate—muscle cancer	0.000126	0.00232	CcSEcCtD
Tenofovir—Abdominal pain—Methotrexate—muscle cancer	0.000122	0.00225	CcSEcCtD
Tenofovir—Body temperature increased—Methotrexate—muscle cancer	0.000122	0.00225	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000122	0.00224	CcSEcCtD
Tenofovir—Insomnia—Doxorubicin—muscle cancer	0.000121	0.00223	CcSEcCtD
Tenofovir—Dyspnoea—Doxorubicin—muscle cancer	0.000119	0.00219	CcSEcCtD
Tenofovir—Dyspepsia—Doxorubicin—muscle cancer	0.000118	0.00217	CcSEcCtD
Tenofovir—Decreased appetite—Doxorubicin—muscle cancer	0.000116	0.00214	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000115	0.00212	CcSEcCtD
Tenofovir—Fatigue—Doxorubicin—muscle cancer	0.000115	0.00212	CcSEcCtD
Tenofovir—Pain—Doxorubicin—muscle cancer	0.000114	0.0021	CcSEcCtD
Tenofovir—Hypersensitivity—Methotrexate—muscle cancer	0.000114	0.00209	CcSEcCtD
Tenofovir—Asthenia—Methotrexate—muscle cancer	0.000111	0.00204	CcSEcCtD
Tenofovir—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000109	0.00201	CcSEcCtD
Tenofovir—Pruritus—Methotrexate—muscle cancer	0.000109	0.00201	CcSEcCtD
Tenofovir—Abdominal pain—Doxorubicin—muscle cancer	0.000106	0.00195	CcSEcCtD
Tenofovir—Body temperature increased—Doxorubicin—muscle cancer	0.000106	0.00195	CcSEcCtD
Tenofovir—Diarrhoea—Methotrexate—muscle cancer	0.000105	0.00194	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000103	0.029	CbGpPWpGaD
Tenofovir—Dizziness—Methotrexate—muscle cancer	0.000102	0.00188	CcSEcCtD
Tenofovir—Hypersensitivity—Doxorubicin—muscle cancer	9.84e-05	0.00181	CcSEcCtD
Tenofovir—Vomiting—Methotrexate—muscle cancer	9.8e-05	0.00181	CcSEcCtD
Tenofovir—ABCC4—Ectoderm Differentiation—PAX3—muscle cancer	9.73e-05	0.0275	CbGpPWpGaD
Tenofovir—Rash—Methotrexate—muscle cancer	9.72e-05	0.00179	CcSEcCtD
Tenofovir—Dermatitis—Methotrexate—muscle cancer	9.71e-05	0.00179	CcSEcCtD
Tenofovir—Headache—Methotrexate—muscle cancer	9.66e-05	0.00178	CcSEcCtD
Tenofovir—Asthenia—Doxorubicin—muscle cancer	9.58e-05	0.00177	CcSEcCtD
Tenofovir—Pruritus—Doxorubicin—muscle cancer	9.44e-05	0.00174	CcSEcCtD
Tenofovir—Nausea—Methotrexate—muscle cancer	9.16e-05	0.00169	CcSEcCtD
Tenofovir—Diarrhoea—Doxorubicin—muscle cancer	9.13e-05	0.00168	CcSEcCtD
Tenofovir—Dizziness—Doxorubicin—muscle cancer	8.83e-05	0.00163	CcSEcCtD
Tenofovir—Vomiting—Doxorubicin—muscle cancer	8.49e-05	0.00156	CcSEcCtD
Tenofovir—Rash—Doxorubicin—muscle cancer	8.42e-05	0.00155	CcSEcCtD
Tenofovir—Dermatitis—Doxorubicin—muscle cancer	8.41e-05	0.00155	CcSEcCtD
Tenofovir—Headache—Doxorubicin—muscle cancer	8.36e-05	0.00154	CcSEcCtD
Tenofovir—Nausea—Doxorubicin—muscle cancer	7.93e-05	0.00146	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	7.5e-05	0.0212	CbGpPWpGaD
Tenofovir—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	7.3e-05	0.0207	CbGpPWpGaD
Tenofovir—AK2—Metabolism—FH—muscle cancer	6.32e-05	0.0179	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—DMD—muscle cancer	6.18e-05	0.0175	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—TP53—muscle cancer	5.1e-05	0.0144	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—IGF2—muscle cancer	4.52e-05	0.0128	CbGpPWpGaD
Tenofovir—NME2—Metabolism—FH—muscle cancer	4.38e-05	0.0124	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	4.3e-05	0.0122	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—TP53—muscle cancer	3.86e-05	0.0109	CbGpPWpGaD
Tenofovir—AK2—Metabolism—MED12—muscle cancer	3.57e-05	0.0101	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	3.32e-05	0.00941	CbGpPWpGaD
Tenofovir—NME1—Metabolism—FH—muscle cancer	3.32e-05	0.0094	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ENO2—muscle cancer	3.26e-05	0.00922	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	3.2e-05	0.00907	CbGpPWpGaD
Tenofovir—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	2.96e-05	0.00839	CbGpPWpGaD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TP53—muscle cancer	2.91e-05	0.00823	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.52e-05	0.00715	CbGpPWpGaD
Tenofovir—NME2—Metabolism—MED12—muscle cancer	2.48e-05	0.00701	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ENO2—muscle cancer	2.26e-05	0.00639	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ANGPT2—muscle cancer	2.12e-05	0.00602	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IGF2—muscle cancer	2e-05	0.00568	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.91e-05	0.0054	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—VEGFA—muscle cancer	1.89e-05	0.00537	CbGpPWpGaD
Tenofovir—NME1—Metabolism—MED12—muscle cancer	1.88e-05	0.00531	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	1.81e-05	0.00511	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ENO2—muscle cancer	1.71e-05	0.00484	CbGpPWpGaD
Tenofovir—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	1.23e-05	0.00348	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	1.19e-05	0.00336	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTGS2—muscle cancer	1.13e-05	0.00321	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	1.11e-05	0.00314	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IGF2—muscle cancer	1.03e-05	0.00293	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	9.34e-06	0.00264	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	8.41e-06	0.00238	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS2—muscle cancer	7.86e-06	0.00223	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS2—muscle cancer	5.96e-06	0.00169	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	4.99e-06	0.00141	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFA—muscle cancer	4.33e-06	0.00123	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—FH—muscle cancer	3.93e-06	0.00111	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—muscle cancer	3.27e-06	0.000927	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MED12—muscle cancer	2.22e-06	0.00063	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ENO2—muscle cancer	2.03e-06	0.000574	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.58e-06	0.000449	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS2—muscle cancer	7.06e-07	0.0002	CbGpPWpGaD
